Search
flavoxate (Urispas, Bladderon)
Tradename: Urispas.
Indications:
- symptomatic relief of dysuria, nocturia, suprapubic pain, urinary frequency, urinary urgency & urinary incontinence
Dosage: 100-200 mg PO TID/QID.
Tabs: 100 mg.
Adverse effects:
1) common (> 10%)
- drowsiness, dry mouth & throat (anti-cholinergic effects)
2) less common (1-10%)
- tachycardia, palpitations, nervousness, fatigue, vertigo, headache, constipation, nausea/vomiting, hyperpyrexia
3) uncommon (< 1%)
- confusion (especially in the elderly), increased intraocular pressure, leukopenia, rash
Mechanism of action: anti-spasmodic agent
Interactions
drug interactions
drug adverse effects of parasympatholytics
General
urinary antispasmodic
Properties
MISC-INFO: elimination route KIDNEY
pregnancy-category B
safety in lactation ?
Database Correlations
PUBCHEM correlations
References
- The Pharmacological Basis of Therapeutics, 9th ed.
Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Kaiser Permanente Northern California Regional Drug
Formulary, 1998